IBRANCE (PALBOCICLIB) — FDA Approval NDA212436 (PFIZER)
IBRANCE (PALBOCICLIB) — FDA Approval NDA212436 (PFIZER) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: IBRANCE; Active ingredients: PALBOCICLIB; Application number: NDA212436.
| Brand name | IBRANCE |
|---|---|
| Active ingredients | PALBOCICLIB |
| Application number | NDA212436 |
| Sponsor | PFIZER |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 3 |
| First approval date | 20191101 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →